Biotech firm Resother is well on the way to clinical trials - lands DKK 16 million
Resother Pharma, which is developing a new type of anti-inflammatory medicine, has secured DKK 16 million (USD 2.4 million) - enough to take the company's first drug to clinical trials.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.